Second-line protease inhibitor-based HAART after failing non-nucleoside reverse transcriptase inhibitorbased regimens in Asian HIV-infected children
Background: The World Health Organization (WHO) recommends boosted protease inhibitor (bPI)-based HAART after failing non-nucleoside reverse transcriptase inhibitor (NNRTI) treatment. We examined outcomes of this regimen in Asian HIV-infected children. Methods: Children from five Asian countries in...
Saved in:
Main Authors: | , , , , , , , , , , , , , , , , , |
---|---|
Other Authors: | |
Format: | Article |
Published: |
2018
|
Subjects: | |
Online Access: | https://repository.li.mahidol.ac.th/handle/123456789/32113 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Mahidol University |
id |
th-mahidol.32113 |
---|---|
record_format |
dspace |
spelling |
th-mahidol.321132018-10-19T12:42:50Z Second-line protease inhibitor-based HAART after failing non-nucleoside reverse transcriptase inhibitorbased regimens in Asian HIV-infected children Torsak Bunupuradah Thanyawee Puthanakit Paul Fahey Azar Kariminia Nik K.N. Yusoff Truong H. Khanh Annette H. Sohn Kulkanya Chokephaibulkit Pagakrong Lumbiganon Rawiwan Hansudewechakul Kamarul Razali Nia Kurniati Bui V. Huy Tavitiya Sudjaritruk Nagalingeswaran Kumarasamy Siew M. Fong Vonthanak Saphonn Jintanat Ananworanich The HIV Netherlands Australia Thailand Research Collaboration Chulalongkorn University University of New South Wales (UNSW) Australia Hospital Raja Perempuan Zainab II Children Hospital Number 1 Foundation for AIDS Research Mahidol University Khon Kaen University Chiangrai Prachanukroh Hospital Kuala Lumpur Hospital University of Indonesia, RSUPN Dr. Cipto Mangunkusumo National Hospital of Pediatrics Hanoi Chiang Mai University YR Gaitonde Centre for AIDS Research and Education Hospital Likas National Pediatric Hospital SEARCH Medicine Pharmacology, Toxicology and Pharmaceutics Background: The World Health Organization (WHO) recommends boosted protease inhibitor (bPI)-based HAART after failing non-nucleoside reverse transcriptase inhibitor (NNRTI) treatment. We examined outcomes of this regimen in Asian HIV-infected children. Methods: Children from five Asian countries in the TREAT Asia Pediatric HIV Observational Database (TApHOD) with ≥24 weeks of NNRTI-based HAART followed by ≥24 weeks of bPI-based HAART were eligible. Primary outcomes were the proportions with virological suppression (HIV RNA<400 copies/ml) and immune recovery (CD4+T-cell percentage [CD4%]≥25% if age <5 years and CD4+T-cell count ≥500 cells/mm3if age ≥5 years) at 48 and 96 weeks. Results: Of 3,422 children, 153 were eligible; 52% were female. At switch, median age was 10 years, 26% were in WHO stage 4. Median weight-for-age z-score (WAZ) was -1.9 (n=121), CD4% was 12.5% (n=106), CD4+T-cell count was 237 cells/mm3(n=112), and HIV RNA was 4.6 log10copies/ml (n=61). The most common bPIwas lopinavir/ritonavir (83%). At 48 weeks, 61% (79/129) had immune recovery, 60% (26/43) had undetectable HIV RNA and 73% (58/79) had fasting triglycerides ≥130 mg/dl. By 96 weeks, 70% (57/82) achieved immune recovery, 65% (17/26) hadvirological suppression, and hypertriglyceridaemia occurred in 66% (33/50). Predictors for virological suppression at week 48 were longer duration of NNRTI-based HAART (P=0.006), younger age (P=0.007), higher WAZ (P=0.020) and HIV RNA at switch <10,000 copies/ml (P=0.049). Conclusions: In this regional cohort of Asian children on bPI-based second-line HAART, 60% of children tested had immune recovery by 1 year, and two-thirds had hyperlipidaemia, highlighting difficulties in optimizing secondline HAART with limited drug options. © 2013 International Medical Press. 2018-10-19T05:14:12Z 2018-10-19T05:14:12Z 2013-10-16 Article Antiviral Therapy. Vol.18, No.4 (2013), 591-598 10.3851/IMP2494 20402058 13596535 2-s2.0-84885343575 https://repository.li.mahidol.ac.th/handle/123456789/32113 Mahidol University SCOPUS https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84885343575&origin=inward |
institution |
Mahidol University |
building |
Mahidol University Library |
continent |
Asia |
country |
Thailand Thailand |
content_provider |
Mahidol University Library |
collection |
Mahidol University Institutional Repository |
topic |
Medicine Pharmacology, Toxicology and Pharmaceutics |
spellingShingle |
Medicine Pharmacology, Toxicology and Pharmaceutics Torsak Bunupuradah Thanyawee Puthanakit Paul Fahey Azar Kariminia Nik K.N. Yusoff Truong H. Khanh Annette H. Sohn Kulkanya Chokephaibulkit Pagakrong Lumbiganon Rawiwan Hansudewechakul Kamarul Razali Nia Kurniati Bui V. Huy Tavitiya Sudjaritruk Nagalingeswaran Kumarasamy Siew M. Fong Vonthanak Saphonn Jintanat Ananworanich Second-line protease inhibitor-based HAART after failing non-nucleoside reverse transcriptase inhibitorbased regimens in Asian HIV-infected children |
description |
Background: The World Health Organization (WHO) recommends boosted protease inhibitor (bPI)-based HAART after failing non-nucleoside reverse transcriptase inhibitor (NNRTI) treatment. We examined outcomes of this regimen in Asian HIV-infected children. Methods: Children from five Asian countries in the TREAT Asia Pediatric HIV Observational Database (TApHOD) with ≥24 weeks of NNRTI-based HAART followed by ≥24 weeks of bPI-based HAART were eligible. Primary outcomes were the proportions with virological suppression (HIV RNA<400 copies/ml) and immune recovery (CD4+T-cell percentage [CD4%]≥25% if age <5 years and CD4+T-cell count ≥500 cells/mm3if age ≥5 years) at 48 and 96 weeks. Results: Of 3,422 children, 153 were eligible; 52% were female. At switch, median age was 10 years, 26% were in WHO stage 4. Median weight-for-age z-score (WAZ) was -1.9 (n=121), CD4% was 12.5% (n=106), CD4+T-cell count was 237 cells/mm3(n=112), and HIV RNA was 4.6 log10copies/ml (n=61). The most common bPIwas lopinavir/ritonavir (83%). At 48 weeks, 61% (79/129) had immune recovery, 60% (26/43) had undetectable HIV RNA and 73% (58/79) had fasting triglycerides ≥130 mg/dl. By 96 weeks, 70% (57/82) achieved immune recovery, 65% (17/26) hadvirological suppression, and hypertriglyceridaemia occurred in 66% (33/50). Predictors for virological suppression at week 48 were longer duration of NNRTI-based HAART (P=0.006), younger age (P=0.007), higher WAZ (P=0.020) and HIV RNA at switch <10,000 copies/ml (P=0.049). Conclusions: In this regional cohort of Asian children on bPI-based second-line HAART, 60% of children tested had immune recovery by 1 year, and two-thirds had hyperlipidaemia, highlighting difficulties in optimizing secondline HAART with limited drug options. © 2013 International Medical Press. |
author2 |
The HIV Netherlands Australia Thailand Research Collaboration |
author_facet |
The HIV Netherlands Australia Thailand Research Collaboration Torsak Bunupuradah Thanyawee Puthanakit Paul Fahey Azar Kariminia Nik K.N. Yusoff Truong H. Khanh Annette H. Sohn Kulkanya Chokephaibulkit Pagakrong Lumbiganon Rawiwan Hansudewechakul Kamarul Razali Nia Kurniati Bui V. Huy Tavitiya Sudjaritruk Nagalingeswaran Kumarasamy Siew M. Fong Vonthanak Saphonn Jintanat Ananworanich |
format |
Article |
author |
Torsak Bunupuradah Thanyawee Puthanakit Paul Fahey Azar Kariminia Nik K.N. Yusoff Truong H. Khanh Annette H. Sohn Kulkanya Chokephaibulkit Pagakrong Lumbiganon Rawiwan Hansudewechakul Kamarul Razali Nia Kurniati Bui V. Huy Tavitiya Sudjaritruk Nagalingeswaran Kumarasamy Siew M. Fong Vonthanak Saphonn Jintanat Ananworanich |
author_sort |
Torsak Bunupuradah |
title |
Second-line protease inhibitor-based HAART after failing non-nucleoside reverse transcriptase inhibitorbased regimens in Asian HIV-infected children |
title_short |
Second-line protease inhibitor-based HAART after failing non-nucleoside reverse transcriptase inhibitorbased regimens in Asian HIV-infected children |
title_full |
Second-line protease inhibitor-based HAART after failing non-nucleoside reverse transcriptase inhibitorbased regimens in Asian HIV-infected children |
title_fullStr |
Second-line protease inhibitor-based HAART after failing non-nucleoside reverse transcriptase inhibitorbased regimens in Asian HIV-infected children |
title_full_unstemmed |
Second-line protease inhibitor-based HAART after failing non-nucleoside reverse transcriptase inhibitorbased regimens in Asian HIV-infected children |
title_sort |
second-line protease inhibitor-based haart after failing non-nucleoside reverse transcriptase inhibitorbased regimens in asian hiv-infected children |
publishDate |
2018 |
url |
https://repository.li.mahidol.ac.th/handle/123456789/32113 |
_version_ |
1763497859842310144 |